Stakeholders Urge Congress To Take Up Diagnostic Reform This Year

By David Roza / May 10, 2018 at 5:35 PM
A coalition of over 80 groups, including manufacturers, providers, laboratories and patient advocates, sent a letter Wednesday (May 9) to key members of Congress attempting to create momentum around passing legislation in 2018 revising government oversight of diagnostics, including laboratory developed tests (LDTs). The unified call for congressional movement comes as FDA is providing technical assistance on a yet-to-be-released revised piece of legislation, which was introduced as a discussion draft last year, according to the letter. While stakeholders see legislation...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.